Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intracellular Delivery of P311 Protein and Scavenge of ROS by Targeting Liposome Promote Fibroblast Differentiation to Myofibroblast and Diabetic Wound Healing via Regulating the GDF-15 Pathway.

ACS applied materials & interfaces·2026
Same author

Bilateral SERS-Microneedle Patch for Co-Diagnosis of Diabetes Mellitus and Tuberculosis Comorbidity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Mucinase-engineered cell membrane nanovesicles degrade the glycocalyx shield to potentiate antitumor immunity.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Engineered blood clots stop bleeding in seconds.

Nature·2026
Same author

Macrophage metabolic reprogramming by vanadium released from glucose-responsive bio-gel accelerates diabetic wound repair.

Signal transduction and targeted therapy·2026
Same author

Metabolic adaptation drives self-organization during skin organoid morphogenesis.

Nature communications·2026
Same journal

Reassessing the Proposed Creatine-PrP Axis in Endometriosis: Methodological and Mechanistic Considerations.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

IL-7R-Enriched Extracellular Vesicles From the Thymus Drive Colitis via Promoting Neutrophil Extracellular Trap Formation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Oral Prebiotic Polysaccharide Hydrogels Sustaining Colon Antibody Release Alleviate Inflammatory Bowel Disease.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Systematic Phosphorus-Driven Structural and Field Engineering of n-a-Si:H for Flexible n-a-Si:H/Te Near-Infrared Photodetectors.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Chemically Gradient Ordered Nanodomains Enable Large Tensile Ductility in Gigapascal Lightweight Refractory High-Entropy Alloys.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Single-Molecule Characterization of Bacterial Factor-Dependent Transcription Activation by Rob.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
See all related articles

Related Experiment Video

Updated: Oct 15, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.4K

Engineered Cell Membrane-Derived Nanoparticles in Immune Modulation.

Yixiao Yang1, Kai Wang2, Yuanwei Pan3

  • 1Institute of Burn Research, The First Affiliated Hospital, State Key Lab of Trauma, Burn and Combined Injury, Chongqing Key Laboratory for Disease Proteomics, Third Military Medical University (Army Medical University), Chongqing, 400038, China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|October 25, 2021
PubMed
Summary
This summary is machine-generated.

Engineered cell membrane-derived nanoparticles (CMDNs) offer improved immune modulation therapies. These nanoparticles overcome limitations of traditional treatments, enhancing efficacy and reducing side effects for complex diseases.

Keywords:
cell membranesengineering strategiesimmunomodulationnanoparticles

More Related Videos

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

10.3K
Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry
07:31

Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry

Published on: March 28, 2014

17.8K

Related Experiment Videos

Last Updated: Oct 15, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.4K
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

10.3K
Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry
07:31

Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry

Published on: March 28, 2014

17.8K

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Nanotechnology

Background:

  • Immune modulation is crucial for treating complex diseases and public health emergencies.
  • Current immune therapeutics (drugs, vaccines, cellular therapy) face challenges with efficacy and adverse effects.
  • Cell membrane-derived nanoparticles (CMDNs) present a promising alternative due to superior compatibility and inherent biological functions.

Purpose of the Study:

  • To review the unique properties of immunomodulatory CMDNs.
  • To summarize engineering strategies for developing advanced CMDNs for immune modulation.
  • To highlight design logic and clinical translation challenges for immunoregulatory CMDNs.

Main Methods:

  • Review of existing literature on cell membrane-derived nanoparticles in immune modulation.
  • Analysis of engineering strategies for tailoring CMDN properties.
  • Discussion of clinical translation hurdles and future prospects.

Main Results:

  • CMDNs leverage cell membrane components for intercellular communication and immune system interaction.
  • Engineered cell membranes are increasingly utilized in CMDNs for enhanced immunomodulatory functions.
  • The plasticity of cell membranes allows for potentiation of CMDNs in immune system regulation.

Conclusions:

  • CMDNs offer a novel platform for advanced immune modulation, overcoming limitations of conventional therapies.
  • Engineering strategies are key to optimizing CMDNs for precise control of the immune system.
  • Addressing clinical translation challenges is essential for realizing the full potential of immunoregulatory CMDNs.